Search

Abstract Preferential listing of a single drug is a common strategy for controlling costs within a drug class. In 2003, the Canadian Forces (CF) drug benefit plan used preferential listing [...]

Focuses on the approval of several new prescription medications that many plan sponsors have labelled as lifestyle drugs. Examples of lifestyle drugs; Definitions related to lifestyle drugs; Findings of the study commissioned by the Canadian Armed Forces to test how effectively coverage was being approved.

Falsely elevated serum digoxin values have recently been reported in patients with liver disease. Since not all patients have circulatory digoxin-like immunoreactive substance (DLIS) in their serum, we compared the clinical and laboratory findings in patients with and without DLIS. Thirty-two patients with liver disease were studied. The only parameter that was significantly different in the two groups was serum bilirubin. In the group of patients with DLIS, significant correlations were obtained between DLIS and bilirubin and DLIS and creatinine. We postulate that increased levels of DLIS in serum are due to an abnormality of DLIS excretion.